Viewing StudyNCT00261612



Ignite Creation Date: 2024-05-05 @ 12:09 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00261612
Status: UNKNOWN
Last Update Posted: 2006-10-18
First Post: 2005-12-01

Brief Title: Bortezomib Rituximab and Dexamethasone BORID for RelapsedRefractory Mantle Cell Lymphoma
Sponsor: Medical University of Vienna
Organization: Medical University of Vienna

Conditions & Keywords Data

Conditions:
Name
Lymphoma Mantle-Cell
Keywords:
Name View
relapsed or chemotherapy-refractory disease View